PD 180988

Known as: CI-1034, CI1034, PD180988 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2009
01220002009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Phenotypic and contractile changes in pulmonary arterial smooth muscle cells (PASMCs) were examined in rats with pulmonary… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 6
Is this relevant?
2006
2006
CI-1034, an endothelin-A receptor antagonist was being developed for pulmonary hypertension. Drug-drug interaction studies using… (More)
Is this relevant?
2006
2006
The objective of this study was to characterize acute coronary artery injury evoked by the endothelin A receptor (ETAR… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Inhibition of canalicular bile acid efflux by medications is associated with clinical liver toxicity, sometimes in the absence of… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2002
2002
Endothelin-1 (ET-1) is considered an intermediary in the constrictor response of the pulmonary vasculature to hypoxia and, by… (More)
  • table 1
  • figure 2
  • figure 4
  • table 2
  • table 3
Is this relevant?
2000
2000
Endothelin-1 (ET-1) is assigned a mediator role in the constrictor response of the pulmonary vasculature to hypoxia. Accordingly… (More)
Is this relevant?